RSC4Earth
RSC4Earth
Home
Mission
Publications
Team
Projects
Contact
Data
Michael Cross
Latest
Activation of Distinct Inflammatory Pathways in LR-MDS Is Determined By Genetics
Prospective Phase II Study of Preemptive Chimerism-Driven Reduction of Immunosuppression after Non-Myeloablative Conditioning—Eudract #: 2007-002420-15
Cite
×